April 4, 2017

A. Schulman Reports Fiscal 2017 Second Quarter, First Half Results

- On GAAP basis, earnings per diluted share were $0.11, compared with a loss of $0.01 in second quarter a year ago; adjusted earnings per diluted share were $0.31, flat on year-over-year basis
- Segment gross margin steady at 15.9%, unchanged from prior year
- Europe operating results exceeded last year despite foreign currency exchange headwinds
- Engineered Composites, Latin America and Asia-Pacific segments also reported strong fiscal second quarter operating results

AKRON, Ohio, April 4, 2017 /PRNewswire/ -- A. Schulman, Inc. (Nasdaq: SHLM) today announced earnings for the fiscal 2017 second quarter and first half of fiscal 2017 ending February 28, 2017. On a GAAP basis, the Company reported earnings per diluted share of $0.11, compared with a loss of $0.01 in the prior year period. Adjusted earnings per diluted share were $0.31, flat on a year-over-year basis. For the first half of fiscal 2017, A. Schulman reported earnings per diluted share of $0.14 on a GAAP basis, compared with $0.17 a year ago. Adjusted earnings per diluted share during this period was $0.80, compared with $0.82 in the first half of fiscal 2016.

Consolidated net sales for the second quarter were $568.7 million, compared with $591.8 million in the second quarter of fiscal 2016. Year-to-date, the Company reported consolidated net sales of $1,168.7 million in fiscal 2017, compared with consolidated net sales of $1,241 million in the first half of fiscal 2016. Excluding the negative impact of foreign currency translation in the second quarter and first half of fiscal 2017 of $12.6 million and $21.9 million, respectively, net sales declined 1.8% in the second quarter and 4.1% in the first half compared with a year ago, primarily due to lower volumes in the EMEA and USCAN segments.

"We've stated this is a reset year; however, I am highly encouraged with the steady progress we are making through the hard work of our teams. During the quarter, we saw strong results in Engineered Composites and experienced continued growth in our Asia-Pacific and Latin America segments related to improved product mix and strength in Performance Materials. Our European business saw a year-over-year improvement in operating income despite the impact of foreign currency, in part, helped by our recent business simplification efforts," said Joseph M. Gingo, chairman, president and chief executive officer. "While our U.S. and Canada region remains challenged by complex plant consolidation efforts, which had been complicated by the Lucent matter, I am confident that we have solid action plans in place to drive future profitability."

Gross profit on a GAAP basis in the second quarter of fiscal 2017 was $89.2 million, compared with $89.8 million in the prior year period. For the first half of fiscal 2017, gross profit on a GAAP basis was $190.2 million, compared with $194.8 million a year ago. Segment gross margin was 15.9% in the second quarter and 16.4% in the first half of fiscal 2017, which is relatively flat with the comparable fiscal 2016 periods.

GAAP operating income in the second quarter was $21.3 million, compared with $16.0 million in the prior year period. Adjusted operating income margin was 4.8% in the second quarter of fiscal 2017, compared with 4.9% in the second quarter of fiscal 2016. On a year-to-date basis, the adjusted operating margin was 5.3%, compared with 5.4% in the prior year.

A. Schulman reported fiscal second quarter net income of $3.2 million, compared with a loss of $0.3 million in the year-ago period.  Year-to-date, reported net income was $4.2 million compared to $4.9 million in the prior six-month period.  On an adjusted basis, the net income comparison for the second quarter was $9.3 million versus $9.2 million in the prior year period.  Year-to-date adjusted net income was $23.7 million, compared with $24.1 million in the prior year period. Fiscal 2017 second quarter adjusted EBITDA was $46.7 million, compared with $49.7 million in the prior year period. Year-to-date, adjusted EBITDA was $101.3 million, compared with $108.1 million in the first six months of fiscal 2016.

Balance Sheet/Cash Flow 
Cash provided from operations for the first half of fiscal 2017 was $40.1 million, compared with $30.6 million in the prior period. Working capital days were 48 days at the end of February 28, 2017, an improvement of 10 days from the comparable period last year.

At quarter-end, net debt (total debt less cash and cash equivalents and restricted cash) stands at $901 million, which equates to a net leverage ratio of 4.06x. Since the purchase of Citadel in mid-2015, the Company has paid down approximately $168 million of total debt.

Business Outlook
The Company's initial annual guidance included an assumed Euro rate of $1.13. While the Company does not generally adjust guidance around currency changes over the course of the fiscal year, if the Euro remains at current levels of approximately $1.06 for the remainder of the fiscal year along with no changes in other world currencies, the full fiscal year negative impact of foreign currency translation would be approximately $0.15 per diluted share and would adversely impact sales by approximately $90 million and EBITDA by approximately $8 million.

Excluding potential 2017 currency translation as noted above, the Company is maintaining its previously stated fiscal 2017 operating targets of $2.5 billion to $2.6 billion in sales, adjusted EBITDA of $225 million to $230 million, and a return on invested capital of 11 percent to 12.5 percent. The outlook for adjusted earnings per diluted share remains in the range of $2.08 to $2.18 on an operating basis.

Gingo stated, "As a result of potential foreign currency headwind, we are intensely focused on continuing to execute our strategy with a sense of urgency. We must deliver tangible benefits from our strengthened global sales organization and aggressively commercialize value-added products in our expanding innovation pipeline."

Gingo noted that the Company is focused on increasing sales in high-demand, high-margin specialized growth niches worldwide. "I believe A. Schulman's expertise, technology and service sets it apart from our competitors. These distinctions will become even more evident as we progress into fiscal 2018."

Please refer to the reconciliation of GAAP and Non-GAAP financial measures for the types of items excluded from the Company's business outlook.

Conference Call on the Web
A live Internet broadcast of A. Schulman's conference call regarding fiscal 2017 second quarter and first half results can be accessed at 10:00 a.m. Eastern Time on April 5, 2017, on the Company's website, www.aschulman.com. An archived replay of the call will also be available on the website.

Investor Presentation Materials
Senior executives may participate in meetings with analysts and investors throughout the fiscal year. The Company has posted presentation materials, portions of which may be used during such meetings, in the Investors section of its website at www.aschulman.com. The presentation will remain on the website as long as it is in use.

About A. Schulman, Inc.
A. Schulman, Inc. is a leading international supplier of high-performance plastic compounds and resins headquartered in Akron, Ohio. Since 1928, the Company has been providing innovative solutions to meet its customers' demanding requirements. The Company's customers span a wide range of markets such as packaging, mobility, building & construction, electronics & electrical, agriculture, personal care & hygiene, sports, leisure & home, custom services and others. The Company employs approximately 4,800 people and has 54 manufacturing facilities globally. A. Schulman reported net sales of approximately $2.5 billion for the fiscal year ended August 31, 2016. Additional information about A. Schulman can be found at www.aschulman.com.

Use of Non-GAAP Financial Measures
This release includes certain financial information determined by methods other than in accordance with accounting principles generally accepted in the United States ("GAAP"). These non-GAAP financial measures include segment gross profit, SG&A expenses excluding certain items, segment operating income, operating income before certain items, net income excluding certain items, net income per diluted share excluding certain items and adjusted EBITDA, as discussed further in the Reconciliation of GAAP and Non-GAAP Financial Measures below. These non-GAAP financial measures are considered relevant to aid analysis and understanding of the Company's results and business trends.

The Company uses segment gross profit, SG&A expenses excluding certain items, segment operating income, operating income before certain items, net income excluding certain items, net income per diluted share excluding certain items and adjusted EBITDA to assess performance and allocate resources because the Company believes that these measures are useful to investors and management in understanding current profitability levels that may serve as a basis for evaluating future performance and facilitating comparability of results. In addition, segment operating income before certain items and net income excluding certain items are important to management as all are a component of the Company's annual and long-term employee incentive plans. Non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures, and tables included in this release reconcile each non-GAAP financial measure with the most directly comparable GAAP financial measure. The most directly comparable GAAP financial measures for these purposes are gross profit, SG&A expenses, operating income, net income and net income per diluted share. The Company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures, and should be read only in conjunction with the Company's consolidated financial statements prepared in accordance with GAAP.

While the Company believes that these non-GAAP financial measures provide useful supplemental information to investors, there are very significant limitations associated with their use. These non-GAAP financial measures are not prepared in accordance with GAAP, may not be reported by all of the Company's competitors and may not be directly comparable to similarly titled measures of the Company's competitors due to potential differences in the exact method of calculation. The Company compensates for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by reviewing the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures.

Cautionary Statements

A number of the matters discussed in this document that are not historical or current facts deal with potential future circumstances and developments and may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the fact that they do not relate strictly to historic or current facts and relate to future events and expectations. Forward-looking statements contain such words as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which management is unable to predict or control, that may cause actual results, performance or achievements to differ materially from those expressed or implied in the forward-looking statements. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements, and that could adversely affect the Company's future financial performance, include, but are not limited to, the following:

  • worldwide and regional economic, business and political conditions, including continuing economic uncertainties in some or all of the Company's major product markets or countries where the Company has operations;
  • the effectiveness of the Company's efforts to improve operating margins through sales growth, price increases, productivity gains, and improved purchasing techniques;
  • competitive factors, including intense price competition;
  • fluctuations in the value of currencies in areas where the Company operates;
  • volatility of prices and availability of the supply of energy and raw materials that are critical to the manufacture of the Company's products, particularly plastic resins derived from oil and natural gas;
  • changes in customer demand and requirements;
  • effectiveness of the Company to achieve the level of cost savings, productivity improvements, growth and other benefits anticipated from acquisitions and the integration thereof, joint ventures and restructuring initiatives;
  • escalation in the cost of providing employee health care;
  • uncertainties regarding the resolution of pending and future litigation and other claims;
  • the performance of the global automotive market as well as other markets served;
  • further adverse changes in economic or industry conditions, including global supply and demand conditions and prices for products;
  • operating problems with our information systems as a result of system security failures such as viruses, cyber-attacks or other causes;
  • our current debt position could adversely affect our financial health and prevent us from fulfilling our financial obligations; and
  • failure of counterparties to perform under the terms and conditions of contractual arrangements, including suppliers, customers, buyers and sellers of a business and other third parties with which the Company contracts.                                                

The risks and uncertainties identified above are not the only risks the Company faces. Additional risk factors that could affect the Company's performance are set forth in the Company's Annual Report on Form 10-K for the fiscal year ended August 31, 2016. In addition, risks and uncertainties not presently known to the Company or that it believes to be immaterial also may adversely affect the Company. Should any known or unknown risks or uncertainties develop into actual events, or underlying assumptions prove inaccurate, these developments could have material adverse effects on the Company's business, financial condition and results of operations.

SHLM_ALL


 

 

A. SCHULMAN, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 



Three months ended


Six months ended


February 28, 2017


February 29, 2016


February 28,
2017


February 29,
2016


(In thousands, except per share data)

Net sales

$

568,678



$

591,761



$

1,168,678



$

1,240,980


Cost of sales

479,492



501,937



978,477



1,046,227


Selling, general and administrative expenses

65,967



71,604



138,342



148,841


Restructuring expense

1,878



2,214



11,422



3,760


Operating income (loss)

21,341



16,006



40,437



42,152


Interest expense

13,107



13,790



26,271



27,408


Foreign currency transaction (gains) losses

1,081



950



1,643



1,679


Other (income) expense, net

674



(269)



(459)



(218)


Income (loss) before taxes

6,479



1,535



12,982



13,283


Provision (benefit) for U.S. and foreign income taxes

1,143



(487)



4,462



3,764


Net income (loss)

5,336



2,022



8,520



9,519


Noncontrolling interests

(306)



(430)



(547)



(834)


Net income (loss) attributable to A. Schulman, Inc.

5,030



1,592



7,973



8,685


Convertible special stock dividends

1,875



1,875



3,750



3,750


Net income (loss) available to A. Schulman, Inc. common stockholders

$

3,155



$

(283)



$

4,223



$

4,935










Weighted-average number of shares outstanding:








Basic

29,394



29,292



29,378



29,257


Diluted

29,503



29,292



29,470



29,455










Net income (loss) per common share available to A. Schulman, Inc. common stockholders








Basic

$

0.11



$

(0.01)



$

0.14



$

0.17


Diluted

$

0.11



$

(0.01)



$

0.14



$

0.17










Cash dividends per common share

$

0.205



$

0.205



$

0.410



$

0.410


Cash dividends per share of convertible special stock

$

15.00



$

15.00



$

30.00



$

30.00



 

 

A. SCHULMAN, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)



February 28,
 2017


August 31,
 2016


(In thousands)

ASSETS

Current assets:




Cash and cash equivalents

$

47,861



$

35,260


Restricted cash

1,623



8,143


Accounts receivable, less allowance for doubtful accounts of $11,411 at February 28, 2017 and $11,341 at August 31, 2016

380,791



376,786


Inventories

279,814



263,617


Prepaid expenses and other current assets

40,837



40,263


Assets held for sale

9,669




Total current assets

760,595



724,069


Property, plant and equipment, at cost:




Land and improvements

29,798



32,957


Buildings and leasehold improvements

170,485



184,291


Machinery and equipment

434,993



447,932


Furniture and fixtures

32,720



34,457


Construction in progress

25,000



20,431


Gross property, plant and equipment

692,996



720,068


Accumulated depreciation

401,288



405,246


Net property, plant and equipment

291,708



314,822


Deferred charges and other noncurrent assets

85,364



88,161


Goodwill

257,507



257,773


Intangible assets, net

344,622



362,614


Total assets

$

1,739,796



$

1,747,439


LIABILITIES AND EQUITY

Current liabilities:




Accounts payable

$

303,160



$

280,060


U.S. and foreign income taxes payable

5,783



8,985


Accrued payroll, taxes and related benefits

41,039



47,569


Other accrued liabilities

66,844



67,704


Short-term debt

28,857



25,447


Total current liabilities

445,683



429,765


Long-term debt

921,312



919,349


Pension plans

138,574



145,108


Deferred income taxes

56,113



59,013


Other long-term liabilities

24,850



25,844


Total liabilities

1,586,532



1,579,079


Commitments and contingencies




Stockholders' equity:




Convertible special stock, no par value

120,289



120,289


Common stock, $1 par value, authorized - 75,000 shares, issued - 48,553 shares at February 28, 2017 and 48,510 shares at August 31, 2016

48,553



48,510


Additional paid-in capital

277,165



275,115


Accumulated other comprehensive income (loss)

(130,640)



(120,721)


Retained earnings

211,205



219,039


Treasury stock, at cost, 19,066 shares at February 28, 2017 and 19,069 shares at August 31, 2016

(382,903)



(382,963)


Total A. Schulman, Inc.'s stockholders' equity

143,669



159,269


Noncontrolling interests

9,595



9,091


Total equity

153,264



168,360


Total liabilities and equity

$

1,739,796



$

1,747,439



 

 

 

A. SCHULMAN, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)



Six months ended


February 28, 2017


February 29, 2016


(In thousands)

Operating activities:




Net income

$

8,520



$

9,519


Adjustments to reconcile net income to net cash provided from (used in) operating activities:




Depreciation

22,215



25,053


Amortization

17,644



20,032


Deferred tax provision (benefit)

(4,493)



(2,360)


Pension, postretirement benefits and other compensation

3,361



2,621


Changes in assets and liabilities, net of acquisitions:




Accounts receivable

(15,866)



10,822


Inventories

(24,670)



4,772


Accounts payable

40,363



(30,846)


Income taxes

(4,639)



(1,491)


Accrued payroll and other accrued liabilities

(4,311)



(5,773)


Other assets and long-term liabilities

2,025



(1,712)


Net cash provided from (used in) operating activities

40,149



30,637


Investing activities




Expenditures for property, plant and equipment

(24,505)



(20,365)


Proceeds from the sale of assets

478



843


Other investing activities

125




Net cash provided from (used in) investing activities

(23,902)



(19,522)


Financing activities:




Cash dividends paid to special stockholders

(3,750)



(3,750)


Cash dividends paid to common stockholders

(12,057)



(12,043)


Increase (decrease) in short-term debt

5,153



4,275


Borrowings on revolving credit facility

238,543



45,655


Repayments of revolving credit facility

(173,895)



(29,900)


Repayments of other long-term debt and capital leases

(63,139)



(61,450)


Issuances of stock, common and treasury

93



148


Redemptions of common stock

(620)



(900)


Net cash provided from (used in) financing activities

(9,672)



(57,965)


Effect of exchange rate changes on cash

(494)



(3,144)


Net increase (decrease) in cash, cash equivalents, and restricted cash

6,081



(49,994)


Cash, cash equivalents, and restricted cash at beginning of period

43,403



96,872


Cash, cash equivalents, and restricted cash at end of period

$

49,484



$

46,878






Cash and cash equivalents

$

47,861



$

46,878


Restricted cash

1,623




Total cash, cash equivalents, and restricted cash

$

49,484



$

46,878



 

 

 

A. SCHULMAN, INC.

Reconciliation of GAAP and Non-GAAP Financial Measures

Unaudited

 

Three months ended February 28, 2017


Cost of
Sales


Gross Margin


SG&A


Restructuring Expense


Operating Income


Non Operating (Income) Expense


Income Tax Expense (Benefit)


Net Income Available to ASI Common Stockholders


Diluted
EPS




(In thousands, except for %'s and per share data)

As reported


$

479,492



15.7

%


$

65,967



$

1,878



$

21,341



$

14,862



$

1,143



$

3,155



$

0.11


Certain items:



















Asset impairment (8)












(1,623)



390



1,233



0.04


Accelerated depreciation (1)


(467)









467





112



355



0.01


Restructuring and related costs (3)


(871)





(2,221)



(1,878)



4,970





1,193



3,777



0.12


Lucent costs (4)






(596)





596





143



453



0.02


CEO transition costs (5)






(6)





6





2



4




Accelerated amortization of debt issuance costs (6)












(21)



5



16




Tax (benefits) charges (7)














(267)



267



0.01


Total certain items


(1,338)



0.2

%


(2,823)



(1,878)



6,039



(1,644)



1,578



6,105



0.20


As Adjusted


$

478,154



15.9

%


$

63,144



$



$

27,380



$

13,218



$

2,721



$

9,260



$

0.31





















Percentage of Revenue






11.1

%




4.8

%






1.6

%






















Effective Tax Rate














19.2

%
























Three months ended February 29, 2016


Cost of
Sales


Gross Margin


SG&A


Restructuring Expense


Operating Income


Non Operating (Income) Expense


Income Tax Expense (Benefit)


Net Income Available to ASI Common Stockholders


Diluted
EPS




(In thousands, except for %'s and per share data)

As reported


$

501,937



15.2

%


$

71,604



$

2,214



$

16,006



$

14,471



$

(487)



$

(283)



$

(0.01)


Certain items:



















Accelerated depreciation (1)


(2,049)





(8)





2,057





479



1,578



0.05


Costs related to acquisitions and integrations (2)


(1,970)





(2,291)





4,261





1,022



3,239



0.11


Restructuring and related costs (3)


(455)





(3,100)



(2,214)



5,769



(84)



1,381



4,472



0.16


Lucent costs (4)


452





(1,063)





611





51



560



0.02


Accelerated amortization of debt issuance costs (6)












(164)



38



126




Tax (benefits) charges (7)














498



(498)



(0.02)


Total certain items


(4,022)



0.7

%


(6,462)



(2,214)



12,698



(248)



3,469



9,477



0.32


As Adjusted


$

497,915



15.9

%


$

65,142



$



$

28,704



$

14,223



$

2,982



$

9,194



$

0.31





















Percentage of Revenue






11.0

%




4.9

%






1.6

%






















Effective Tax Rate














20.6

%





 

 

Six months ended February 28, 2017


Cost of
Sales


Gross
Margin


SG&A


Restructuring
Expense


Operating
Income


Non
Operating
(Income)
Expense


Income
Tax
Expense
(Benefit)


Net Income
Available to ASI
Common
Stockholders


Diluted
EPS




(In thousands, except for %'s and per share data)

As reported


$

978,477



16.3

%


$

138,342



$

11,422



$

40,437



$

27,455



$

4,462



$

4,223



$

0.14


Certain items:



















Asset impairment (8)






(678)





678



(1,623)



552



1,749



0.06


Accelerated depreciation (1)


(822)





(1)





823





197



626



0.02


Costs related to acquisitions and integrations (2)


(57)





(548)





605





145



460



0.02


Restructuring and related costs (3)


(1,043)





(5,778)



(11,422)



18,243





4,378



13,865



0.46


Lucent costs (4)


(86)





(1,319)





1,405





337



1,068



0.04


CEO transition costs (5)






(196)





196





47



149



0.01


Accelerated amortization of debt issuance costs (6)












(227)



54



173



0.01


Tax (benefits) charges (7)














(1,347)



1,347



0.05


Total certain items


(2,008)



0.1

%


(8,520)



(11,422)



21,950



(1,850)



4,363



19,437



0.67


As Adjusted


$

976,469



16.4

%


$

129,822



$



$

62,387



$

25,605



$

8,825



$

23,660



$

0.80





















Percentage of Revenue






11.1

%




5.3

%






2.0

%






















Effective Tax Rate














24.0

%
























Six months ended February 29, 2016


Cost of
Sales



Gross
Margin
 


SG&A


Restructuring
Expense


Operating
Income


Non
Operating
(Income)
Expense


Income
Tax
Expense
(Benefit)


Net Income
Available to ASI
Common
Stockholders


Diluted
EPS




(In thousands, except for %'s and per share data)

As reported


$

1,046,227



15.7

%


$

148,841



$

3,760



$

42,152



$

28,869



$

3,764



$

4,935



$

0.17


Certain items:



















Accelerated depreciation (1)


(3,496)





(14)





3,510





885



2,625



0.09


Costs related to acquisitions and integrations (2)


(2,099)





(4,028)





6,127





1,544



4,583



0.15


Restructuring and related costs (3)


(885)





(5,794)



(3,760)



10,439



(361)



2,772



8,028



0.27


Lucent costs (4)


(1,378)





(2,939)





4,317





1,088



3,229



0.11


Accelerated amortization of debt issuance costs (6)












(274)



69



205



0.01


Tax (benefits) charges (7)














(467)



467



0.02


Total certain items


(7,858)



0.6

%


(12,775)



(3,760)



24,393



(635)



5,891



19,137



0.65


As Adjusted


$

1,038,369



16.3

%


$

136,066



$



$

66,545



$

28,234



$

9,655



$

24,072



$

0.82





















Percentage of Revenue






11.0

%




5.4

%






1.9

%






















Effective Tax Rate














25.2

%





 

1 - Accelerated depreciation is related to restructuring plans in the Company's USCAN and EMEA segments.

2 - Costs related to acquisitions and integrations primarily include third party professional, legal, IT and other expenses associated with successful and unsuccessful full or partial acquisition and divestiture/dissolution transactions, as well as certain employee-related expenses such as travel, one-time bonuses and post-acquisition severance separate from a formal restructuring plan.

3 - Restructuring and related costs include items such as employee severance charges, lease termination charges, curtailment gains/losses, other employee termination costs and charges related to the reorganization of the legal entity structure. Refer to Note 12 in the Company's Quarterly Report on Form 10-Q for further discussion.

4 - Lucent costs primarily represent legal and investigation costs related to resolving the Lucent matter, product manufacturing costs for reworking existing Lucent inventory, obsolete Lucent inventory reserve costs, and dedicated internal personnel costs that would have otherwise been focused on normal operations.

5 - CEO transition costs represent charges for deferred compensation granted to Bernard Rzepka.

6 - Write off of debt issuance costs are related to prepayments of $56.0 million of Term Loan B. Refer to Note 3 in the Company's Quarterly Report on Form 10-Q for further discussion.

7 - Tax (benefits) charges represent the Company's quarterly non-GAAP tax based on the overall estimated annual non-GAAP effective tax rates.

8 - Asset impairment relates to the discontinuation of information technology assets in the USCAN segment and future cash settlement of a commitment to a local government.


 

A. SCHULMAN, INC.

ADJUSTED EBITDA RECONCILIATION

(Unaudited)



Three months ended


Six months ended


February 28, 2017


February 29, 2016


February 28, 2017


February 29, 2016


(In thousands)









Net income available to A. Schulman, Inc. common stockholders

$

3,155



$

(283)



$

4,223



$

4,935


     Interest expense

13,107



13,790



26,271



27,408


     Provision for U.S. and foreign income taxes

1,143



(487)



4,462



3,764


     Depreciation and amortization

19,870



23,033



39,859



45,085


     Noncontrolling interests

306



430



547



834


     Convertible special stock dividends

1,875



1,875



3,750



3,750


     Other (1)

1,755



681



1,184



1,461


EBITDA, as calculated

$

41,211



$

39,039



$

80,296



$

87,237


     Non-GAAP Adjustments (2)

5,467



10,650



21,023



20,886


EBITDA, as adjusted

$

46,678



$

49,689



$

101,319



$

108,123










 

(1) - Other includes Foreign currency transaction (gains) losses and Other (income) expense, net.

(2) - For details on Non-GAAP adjustments, refer to "Reconciliation of GAAP and Non-GAAP Financial Measures", items (2) - (8).  Amounts are included in Operating Income. Accelerated depreciation on the "Reconciliation of GAAP and Non-GAAP Financial Measures" has been excluded as it is already included in Depreciation and amortization above.


 

 

A. SCHULMAN, INC.

SUPPLEMENTAL SEGMENT INFORMATION

(Unaudited)




Net Sales


Net Sales



Three months ended


Six months ended

EMEA


February
28, 2017


February
29, 2016


$ Change


% Change


February
28, 2017


February
29, 2016


$ Change


% Change



(In thousands, except for %'s)

Custom Concentrates and Services


$

149,085



$

154,782



$

(5,697)



(3.7)

%


$

307,118



$

328,911



$

(21,793)



(6.6)

%

Performance Materials


127,817



135,548



(7,731)



(5.7)

%


265,856



289,515



(23,659)



(8.2)

%

Total EMEA


$

276,902



$

290,330



$

(13,428)



(4.6)

%


$

572,974



$

618,426



$

(45,452)



(7.3)

%




















Net Sales


Net Sales



Three months ended


Six months ended

USCAN


February
28, 2017


February
29, 2016


$ Change


% Change


February
28, 2017


February
29, 2016


$ Change


% Change



(In thousands, except for %'s)

Custom Concentrates and Services


$

59,956



$

63,160



$

(3,204)



(5.1)

%


$

122,882



$

127,313



$

(4,431)



(3.5)

%

Performance Materials


91,962



107,657



(15,695)



(14.6)

%


185,454



221,786



(36,332)



(16.4)

%

Total USCAN


$

151,918



$

170,817



$

(18,899)



(11.1)

%


$

308,336



$

349,099



$

(40,763)



(11.7)

%




















Net Sales


Net Sales



Three months ended


Six months ended

LATAM


February
28, 2017


February
29, 2016


$ Change


% Change


February
28, 2017


February
29, 2016


$ Change


% Change



(In thousands, except for %'s)

Custom Concentrates and Services


$

27,374



$

28,399



$

(1,025)



(3.6)

%


$

57,343



$

62,412



$

(5,069)



(8.1)

%

Performance Materials


12,288



9,759



2,529



25.9

%


24,535



20,949



3,586



17.1

%

Total LATAM


$

39,662



$

38,158



$

1,504



3.9

%


$

81,878



$

83,361



$

(1,483)



(1.8)

%




















Net Sales


Net Sales



Three months ended


Six months ended

APAC


February
28, 2017


February
29, 2016


$ Change


% Change


February
28, 2017


February
29, 2016


$ Change


% Change



(In thousands, except for %'s)

Custom Concentrates and Services


$

23,171



$

22,118



$

1,053



4.8

%


$

48,162



$

45,660



$

2,502



5.5

%

Performance Materials


25,743



22,945



2,798



12.2

%


51,489



45,095



6,394



14.2

%

Total APAC


$

48,914



$

45,063



$

3,851



8.5

%


$

99,651



$

90,755



$

8,896



9.8

%




















Net Sales


Net Sales



Three months ended


Six months ended

Consolidated


February
28, 2017


February
29, 2016


$ Change


% Change


February
28, 2017


February
29, 2016


$ Change


% Change



(In thousands, except for %'s)

Engineered Composites


$

51,282



$

47,393



$

3,889



8.2

%


$

105,839



$

99,339



$

6,500



6.5

%

Custom Concentrates and Services


259,586



268,459



(8,873)



(3.3)

%


535,505



564,296



(28,791)



(5.1)

%

Performance Materials


257,810



275,909



(18,099)



(6.6)

%


527,334



577,345



(50,011)



(8.7)

%

Total Consolidated


$

568,678



$

591,761



$

(23,083)



(3.9)

%


$

1,168,678



$

1,240,980



$

(72,302)



(5.8)

%


















 

 



Segment Gross Profit


Segment Gross Profit



Three months ended


Six months ended



February
28, 2017


February
29, 2016


$ Change


% Change


February
28, 2017


February
29, 2016


$ Change


% Change



(In thousands, except for %'s)









EMEA


$

39,130



$

38,953



$

177



0.5

%


$

83,788



$

86,637



$

(2,849)



(3.3)

%

USCAN


20,060



27,241



(7,181)



(26.4)

%


44,576



57,535



(12,959)



(22.5)

%

LATAM


9,595



8,466



1,129



13.3

%


19,012



18,171



841



4.6

%

APAC


8,908



8,199



709



8.6

%


18,034



16,073



1,961



12.2

%

EC


12,831



10,987



1,844



16.8

%


26,799



24,195



2,604



10.8

%

Total segment gross profit


$

90,524



$

93,846



$

(3,322)



(3.5)

%


$

192,209



$

202,611



$

(10,402)



(5.1)

%

Accelerated depreciation and restructuring related costs


(1,338)



(2,504)



1,166



(46.6)

%


(1,865)



(4,381)



2,516



(57.4)

%

Costs related to acquisitions and integrations




(1,970)



1,970



%


(57)



(2,099)



2,042



(97.3)

%

Lucent costs (1)




452



(452)



%


(86)



(1,378)



1,292



(93.8)

%

Total gross profit


$

89,186



$

89,824



$

(638)



(0.7)

%


$

190,201



$

194,753



$

(4,552)



(2.3)

%


















 (1)Refer to Note 13, Commitments and Contingencies, for additional discussion on this matter. Lucent costs in cost of sales include additional product and manufacturing operational costs for reworking inventory.  Lucent costs in selling, general and administrative expenses include legal and investigative costs. In addition, in the three and six months ended February 29, 2016, Lucent costs in SG&A also include dedicated internal personnel costs that would have otherwise been focused on normal operations.

(2)Restructuring related costs for the three and six months ended February 28, 2017 of $3.1 million and $6.8 million, respectively, and for the three and six months ended February 29, 2016 of $3.6 million and $6.7 million, respectively, primarily included in selling, general and administrative expenses in the Company's statements of operations, are costs associated with professional fees for outside strategic consultants regarding actions to improve the profitability of the organization and efficiency of its operations, and costs associated with reorganizations of the legal entity structure of the Company.  Restructuring expenses included in restructuring expense in the Company's statement of operations include costs permitted under ASC 420, Exit or Disposal Obligations, such as severance costs, outplacement services and contract termination costs.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/a-schulman-reports-fiscal-2017-second-quarter-first-half-results-300434573.html

SOURCE A. Schulman, Inc.

News Provided by Acquire Media


Close window | Back to top


Copyright 2017 A. Schulman, Inc.